OCEANS: A randomized, double-blinded, placebo-controlled phase III trial of chemotherapy with or without bevacizumab (BEV) in patients with platinum-sensitive recurrent epithelial ovarian (EOC), primary peritoneal (PPC), or fallopian tube cancer (FTC) Meeting Abstract
| Authors: | Aghajanian, C.; Finkler, N. J.; Rutherford, T.; Smith, D. A.; Yi, J.; Parmar, H.; Nycum, L. R.; Sovak, M. A. |
| Abstract Title: | OCEANS: A randomized, double-blinded, placebo-controlled phase III trial of chemotherapy with or without bevacizumab (BEV) in patients with platinum-sensitive recurrent epithelial ovarian (EOC), primary peritoneal (PPC), or fallopian tube cancer (FTC) |
| Meeting Title: | 47th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 29 |
| Issue: | 18 Suppl. |
| Meeting Dates: | 2011 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2011-06-20 |
| Language: | English |
| ACCESSION: | WOS:000208865800024 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2011.29.18_suppl.lba5007 |
| Notes: | Meeting Abstract: LBA5007 -- Source: Wos |
